Collaborative Interdisciplinary Team Science in Diabetes, Endocrinology and Metabolic Diseases (R24)

The summary for the Collaborative Interdisciplinary Team Science in Diabetes, Endocrinology and Metabolic Diseases (R24) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Collaborative Interdisciplinary Team Science in Diabetes, Endocrinology and Metabolic Diseases (R24): -Purpose. The purpose of the Collaborative Interdisciplinary Team Science Program described in this announcement is to provide support to enable strong investigative teams to do inter- and/or trans-disciplinary research on a complex problem in biomedical science relevant to Diabetes, Endocrinology and Metabolic Diseases. -Mechanism of Support. This FOA will utilize the Research Resource Grant Mechanism (R24). -Funds Available and Anticipated Number of Awards. It is anticipated that 1-3 projects will be funded per year, but because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received, as well as on the availability of funds.

Federal Grant Title:	Collaborative Interdisciplinary Team Science in Diabetes, Endocrinology and Metabolic Diseases (R24)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Food and Nutrition Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PAR-08-182
Type of Funding:	Grant
CFDA Numbers:	93.837
CFDA Descriptions:	Heart and Vascular Diseases Research
Current Application Deadline:	Mar 24, 2011
Original Application Deadline:	Mar 24, 2011
Posted Date:	Dec 03, 2008
Creation Date:	Dec 03, 2008
Archive Date:	Apr 24, 2011
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Public and State controlled institutions of higher education - Private institutions of higher education - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Non-domestic (non-U.S.) Entities (Foreign Organizations); Tribally Controlled Colleges and Universities (TCCUs) .
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants: • Chronic Kidney Disease in Children Central Biochemistry Laboratory (U24 Clinical Trial Not...; • Limited Competition for Continuation of the Prospective Study of Chronic Kidney Disease in...; • Limited Competition for Continuation of the Prospective Study of Chronic Kidney Disease in...; • ARDS, Pneumonia, and Sepsis Phenotyping Consortium Clinical Centers (U01 Clinical Trial No...; • The Relationship Between Hypertension and Inflammation; • Community-Responsive Interventions to Reduce Cardiovascular Risk in American Indians and A...; • Weight Loss in Obese Adults with Cardiovascular Risk Factors: Clinical Interventions (U01)
More Grants from the National Institutes of Health: • SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies...; • Small Business Transition Grant For Early Career Scientists (R41/R42 Clinical Trial Not Al...; • Cystic Fibrosis Research and Translation Centers (P30 Clinical Trial Optional); • Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial No...; • Mentored Quantitative Research Development Award (Parent K25 Independent Basic Experimenta...